Cue Health is a healthcare technology company focused on developing and manufacturing consumer and professional medical diagnostic products that can be used in clinical or at-home settings.

Cue Health's mission is to create tools that empower physicians and consumers by increasing their access to actionable data.

Cue Health was founded in 2010 by Ayub Khattak and Clint Sever. The company is headquartered in San Diego, California.

Cue enables people to manage their health through real-time, actionable and connected health data. Cue offers individuals and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point-of-care, all in a device that fits in the palm of your hand.

Cue’s first product, the Cue Health Monitoring System, is a connected diagnostic platform designed to deliver a broad menu of tests through one system and is currently being used for COVID-19 testing in enterprises, schools, nursing homes, hospitals, physicians' offices etc.

Cue plans to develop a suite of offerings to address respiratory health, sexual health, cardiac and metabolic health, women's health, men's health, and chronic disease management by connecting diagnostics with telemedicine.

Cue is backed by JJDC, Perceptive Advisors, MSD Capital, Koch Strategic Platforms, Pritzker Group Venture Capital, Decheng Capital, Foresite Capital, and others. The company closed a $235M in new financing on May 13, 2021. This brings Cue's total funding to $899.6M to date.

 $100M in Series C round on June 10, 2020. This brings Cue's total funding to $168M to date. Cue has been awarded $13M contract on Mar 31, 2020.